Entera Bio (ENTX) executive compensation, 2026 proxy

Miranda Toledano, Chief Executive Officer and director, was paid $1.5M in 2025, up 29% from $1.1M the year before.

Filed
October 14, 2026
Annual meeting
November 24, 2026
Pay year
2025
Named executives
3
CEO total pay
$1.5M+29% vs prior year
CEO pay in equity
62%$920,000 in awards
CEO option awards
$590,0002025
CEO RSU awards
$330,0002025
COO total compensation
$531,0002025
Research chief total
$504,0002025

How Toledano was paid

$1.5M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary35%Stock awards23%Option awards42%

Named executive officers

ExecutiveTotal
Miranda ToledanoChief Executive Officer and director$1,482,000
Hillel GalitzerChief Operating Officer$531,000
Gregory BurshteinChief of Research and Development$504,000

What changed and why

  • $1.482M$1.482 million was Miranda Toledano’s 2025 total compensation, compared with $1.149 million in 2024.
  • $590K$590,000 in CEO option awards and $330,000 in RSU awards were reported for 2025.
  • RSUs were granted in place of annual cash bonuses.
  • The company proposes one-time equity grants to the CEO, CFO, COO, and Chief of Research and Development.
  • Non-executive directors received fully vested shares instead of quarterly cash payments for 2025 services; cash compensation was reinstated effective July 1, 2026.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.